review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1590/S0365-05962010000200022 |
P698 | PubMed publication ID | 20520947 |
P2093 | author name string | Georgi Tchernev | |
Pietro Nenoff | |||
P2860 | cites work | Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins | Q24302494 |
Natural selection of tumor variants in the generation of "tumor escape" phenotypes | Q24551158 | ||
The kiss of death: promises and failures of death receptors and ligands in cancer therapy | Q28206616 | ||
The transcriptional targets of p53 in apoptosis control | Q28248026 | ||
Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors | Q28259065 | ||
The mitochondrial serine protease HtrA2/Omi: an overview | Q28263602 | ||
Dissecting the pathways to death | Q33181665 | ||
Loss of proapoptotic Bcl-2-related multidomain proteins in primary melanomas is associated with poor prognosis | Q33236007 | ||
HLA-G: a tolerance molecule from the major histocompatibility complex | Q33546847 | ||
The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors? | Q34064605 | ||
Caspases: more than just killers? | Q34207528 | ||
Tumor counterattack: fact or fiction? | Q34418305 | ||
Tumor escape from killing: role of killer inhibitory receptors and acquisition of tumor resistance to cell death. | Q35020684 | ||
The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors. | Q35052176 | ||
A decade of caspases | Q35591686 | ||
Tumour escape: antitumour effectors too much of a good thing? | Q35611475 | ||
Regulation of caspase-9 activity by differential binding to the apoptosome complex | Q35792765 | ||
Caspases, IAPs and Smac/DIABLO: mechanisms from structural biology | Q35874476 | ||
Alternative splicing of Bcl-2-related genes: functional consequences and potential therapeutic applications. | Q35874924 | ||
Positive and negative consequences of Fas/Fas ligand interactions in the antitumor response | Q35966393 | ||
Transcription, apoptosis and p53: catch-22. | Q36056198 | ||
Escape from immune- and nonimmune-mediated tumor surveillance. | Q36248405 | ||
HLA-G in human reproduction: aspects of genetics, function and pregnancy complications | Q36310336 | ||
Antigen mimicry, epitope spreading and the pathogenesis of pemphigus | Q36616541 | ||
Bim and the pro-survival Bcl-2 proteins: opposites attract, ERK repels | Q36946423 | ||
Non-peptidic small molecule inhibitors against Bcl-2 for cancer therapy. | Q36960751 | ||
TW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and induces apoptosis in pancreatic cancer: involvement of Notch-1 signaling pathway | Q37232979 | ||
HLA-G is expressed by the glandular epithelium of peritoneal endometriosis but not in eutopic endometrium | Q38440107 | ||
Preclinical studies of TW-37, a new nonpeptidic small-molecule inhibitor of Bcl-2, in diffuse large cell lymphoma xenograft model reveal drug action on both Bcl-2 and Mcl-1. | Q40150524 | ||
Expression of FasL in squamous cell carcinomas of the cervix and cervical intraepithelial neoplasia and its role in tumor escape mechanism | Q40320998 | ||
Autocrine secretion of Fas ligand shields tumor cells from Fas-mediated killing by cytotoxic lymphocytes | Q40514646 | ||
Induction and endoplasmic reticulum location of BIK/NBK in response to apoptotic signaling by E1A and p53. | Q40736238 | ||
A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape | Q40736274 | ||
Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xL. | Q40980272 | ||
Inhibitory MHC class I receptors on NK cells and T cells | Q41113089 | ||
The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. | Q42064781 | ||
Arsenic trioxide (As(2)O(3)) induces apoptosis through activation of Bax in hematopoietic cells | Q45286126 | ||
Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity. | Q53271841 | ||
Frameshift Mutations in the Bax Gene Are Not Involved in Development of Ovarian Endometrioid Carcinoma | Q53374898 | ||
[Cell cycle control, genetic instability and cancer] | Q53445435 | ||
P433 | issue | 2 | |
P304 | page(s) | 248-259 | |
P577 | publication date | 2010-03-01 | |
P1433 | published in | Anais Brasileiros de Dermatologia | Q15750855 |
P1476 | title | [Dissecting the pathways of tumour escape: " question of life and death?"]. | |
P478 | volume | 85 |
Q47600992 | Pathways of tumor development and progression in drug-induced nonmelanoma skin cancer: a new hope or the next great confusion? | cites work | P2860 |